Orgenesis Inc. Net Income

Net Income of ORGS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Income growth rates and interactive chart. Net income (NI), also called net earnings, is calculated as sales minus cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes, and other expenses. It is the profit available to all shareholders, both preferred and common.


Highlights and Quick Summary

  • Net Income for the quarter ending September 29, 2021 was $-10.2 Million (a 272.51% increase compared to previous quarter)
  • Year-over-year quarterly Net Income decreased by -77.95%
  • Annual Net Income for 2020 was $579 Thousand (a -102.22% decrease from previous year)
  • Annual Net Income for 2019 was $-26 Million (a 18.31% increase from previous year)
  • Annual Net Income for 2018 was $-22 Million (a 15.22% increase from previous year)
  • Twelve month Net Income ending September 29, 2021 was $-59.1 Million (a 15.03% increase compared to previous quarter)
  • Twelve month trailing Net Income decreased by -10303.45% year-over-year
Trailing Net Income for the last four month:
29 Sep '21 29 Jun '21 30 Mar '21 30 Dec '20
$-59.1 Million $-51.4 Million $-69 Million $579 Thousand
Visit stockrow.com/ORGS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Income of Orgenesis Inc.

Most recent Net Incomeof ORGS including historical data for past 10 years.

Interactive Chart of Net Income of Orgenesis Inc.

Orgenesis Inc. Net Income for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $-10.15 $-2.73 $-0.17
2020 $-46.04 $-2.43 $-20.4 $69.45 $0.58
2019 $-6.85 $-4.91 $-5.83 $-8.45 $-26.04
2018 $12.22 $-4.27 $-2.48 $-5.48 $-22.01
2017 $-3.94 $-2.49 $0.0 $-6.13 $-12.37
2016 $6.31 $3.67 $-2.65 $0.0 $-3.67 $0.0 $-11.11
2015 $-4.46 $-4.46
2014 $-5.5 $-5.5
2013 $0.0 $-5.54
2012 $0.0 $0.0
2011 $0.0

Business Profile of Orgenesis Inc.

Sector: Healthcare
Industry: Biotechnology
Orgenesis Inc., a biotech company, focusing on cell and gene therapies (CGTs). The company develops a Point of Care (POCare) platform includes three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company's POCare Network brings together patients, doctors, industry partners, research institutes, and hospitals for the clinical development and production of therapies worldwide. Orgenesis Inc. has a collaboration agreement with Savicell Diagnostics Ltd. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.